
Loading, please wait...

Loading, please wait...

Accurate cannabinoid isomer identification is a critical requirement in both forensic toxicology and the emerging field of medicinal cannabis. While the therapeutic use of compounds like cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) grows, the ability to distinguish these structural isomers remains technically demanding. Traditional methods often struggle with thermal instability or identical spectral profiles. This can lead to potential misidentification in legal and clinical settings.
For decades, Gas Chromatography-Electron Ionization-Mass Spectrometry (GC-EI-MS) has been the gold standard for analysis. However, the high temperatures in the GC inlet can cause thermal degradation. Furthermore, it often converts acidic cannabinoids into their neutral forms. In contrast, Liquid Chromatography-Mass Spectrometry (LC-MS) offers a gentler approach. However, even with electrospray ionization (ESI), structural isomers like THC and CBD often yield nearly identical product ion spectra. This similarity significantly reduces the effectiveness of cannabinoid isomer identification using standard tandem mass spectrometry (MS/MS).
Recent research introduces a transformative approach using copper (Cu) salts to induce molecular ion formation. By introducing Cu ions under ESI conditions, analysts can create unique molecular complexes. These copper-cannabinoid adducts exhibit fragmentation patterns similar to electron ionization spectra but without the thermal risks. Additionally, this method allows for the differentiation of thirteen different cannabinoids by producing characteristic ions that act as chemical fingerprints. Therefore, this approach provides a more reliable analytical pathway.
This alternative workflow aligns with the needs of drug analysts and clinicians who require high-confidence data. The generated spectra can be searched against established EI-MS libraries, such as the NIST library. Moreover, the successful application of this technique to real-world cannabis plant extracts demonstrates its robustness. For healthcare providers, these advancements ensure that prescribed cannabinoid products meet strict purity standards. Consequently, patients receive medications that are free from illicit or unintended isomers.
Differentiation is essential because isomers like THC and CBD have vastly different legal statuses and pharmacological effects. Misidentification can lead to incorrect dosing or legal complications for patients and providers.
Copper ions help form unique molecular complexes that fragment into distinct "fingerprint" ions. This allows mass spectrometers to see differences between molecules that otherwise look identical under standard testing conditions.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or legal guidance regarding the use of cannabinoids. Refer to the latest local and national guidelines for clinical practice.
References
Couch AN et al. Differentiation of cannabinoid isomers via Cu-mediated molecular ion formation and electrospray ionization-tandem mass spectrometry. J Forensic Sci. 2026 Mar 08. doi: 10.1111/1556-4029.70290. PMID: 41796083.
Couch AN, Zall CM, Davidson JT. Differentiation of CBD and Δ9-THC isomers using copper-ion complexation and electrospray ionization-tandem mass spectrometry. Anal Chim Acta. 2026 Jan 22;1384:344953. doi: 10.1016/j.aca.2025.344953.
Pichini S, et al. Analysis of Cannabinoids in Biological Specimens: An Update. Toxics. 2020;8(1):7. doi: 10.3390/toxics8010007.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a new Cu-mediated ESI-MS/MS method to differentiate cannabinoid isomers, offering a highly accurate alternative to traditional GC...
7 months ago

A pioneering clinical trial across 200 general practices in England evaluates cutting-edge blood tests to detect vague abdominal malignancies earlier. By combining artificial intelligence with protein biomarker profiling, clinicians aim to triage high-risk patients rapidly and improve long-term survival.
Today

A preclinical study reveals that cinnamic acid counters D-galactose-induced premature ovarian failure in mice. By enhancing total antioxidant capacity and upregulating protective genes like Nrf2 and Foxo3a, cinnamic acid improved estrous cyclicity and follicular reserve, offering new insights into ovarian health.
Today

A systematic review of 18 studies reveals very low certainty evidence for cardiac autonomic modulation following intermittent normobaric hypoxia, showing insufficient data to confirm reproducible changes in heart rate variability or baroreflex sensitivity.
Today

An 8-week functional restoration program provides sustained psychological benefits at six-month follow-up for workers' compensation patients. The multidisciplinary intervention significantly improved pain self-efficacy, reduced anxiety and depression, and progressively resolved chronic insomnia severity.
Today

A multinational study of 2,573 medullary thyroid cancer patients refines AJCC TNM-8 staging, proposing N1c for level VII nodes and a new I-IVB schema for better survival stratification.
Today